mRNA Booster Vaccine(SW-BIC-213) Compared With Pfizer andSinopharm Against Emerging VOCs

NCT05686161 · clinicaltrials.gov ↗

PHASE3

Phase

UNKNOWN

Status

600

Enrollment

INDUSTRY

Sponsor class

Conditions

Immunogenicity
Safety
Efficacy

Interventions

BIOLOGICAL: SW-BIC-213;SARS-Cov-2.
BIOLOGICAL: Sinopharm (BIBP);SARS-Cov-2.
BIOLOGICAL: Pfizer(BNT162b2);SARS-Cov-2.

Sponsor

Stemirna Therapeutics